ALDA members participate in the $45 billion analytical and life science research tools industry and in the emerging molecular diagnostics market, estimated at $4 billion in size. Many molecular diagnostics companies also have strong ties to ALDA’s life science members. In addition to instrument platforms, ALDA member companies supply reagents, consumables, and services that support instrument operation, as well as preparations and assays in kit form that provide test results without the need for additional hardware.
Analytical and Life Science Market
The analytical and life science market is highly dynamic, with rapid growth and proliferation of new technologies, instrument techniques, and assays. Members’ businesses focus on critical societal needs, providing important support to development of disease-fighting drugs, advanced materials, food safety and testing, and safeguards for the environment and national security.
Molecular Diagnostics Market
Many ALDA members participate in the emerging molecular diagnostics market, which is experiencing annual growth at 10-15 percent. This market is specific to molecular diagnostics, companion diagnostics, and emerging and next-generation diagnostic technologies. It does not include classical clinical and immumo in vitro diagnostics.
A Global Focus
Our industry addresses global markets. Major industrialized countries in North America, Europe, and Japan represent nearly 80 percent of the current global market. Growth is increasingly focused on developing areas, especially China (8 percent) and the Asia-Pacific region, including India (7 percent).
A Wide Range of Users
Although our member companies serve virtually every industry in one way or another, four customer sectors represent almost 50 percent of the total global user market. Academia, pharmaceutical, biotechnology, and government research are heavily focused on life science-related activities. When contract research organizations, hospital and clinical applications, agriculture/food, and government testing users are added, life science applications account for 66 percent of the global user market.